170 related articles for article (PubMed ID: 7809472)
1. Clinical trials in Mycobacterium avium therapy: lessons to take home.
Dautzenberg B
Res Microbiol; 1994; 145(3):197-206. PubMed ID: 7809472
[No Abstract] [Full Text] [Related]
2. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
[TBL] [Abstract][Full Text] [Related]
3. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
[TBL] [Abstract][Full Text] [Related]
4. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome.
Benson CA; Williams PL; Currier JS; Holland F; Mahon LF; MacGregor RR; Inderlied CB; Flexner C; Neidig J; Chaisson R; Notario GF; Hafner R;
Clin Infect Dis; 2003 Nov; 37(9):1234-43. PubMed ID: 14557969
[TBL] [Abstract][Full Text] [Related]
5. Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy.
Heifets LB
Res Microbiol; 1994; 145(3):188-96. PubMed ID: 7809471
[No Abstract] [Full Text] [Related]
6. Progress report: prophylaxis and therapy for MAC.
Currier J
AIDS Clin Care; 1996 Jun; 8(6):45-8. PubMed ID: 11363599
[TBL] [Abstract][Full Text] [Related]
7. Uveitis during treatment of disseminated Mycobacterium avium-intracellulare complex infection with the combination of rifabutin, clarithromycin and ethambutol.
Lowe SH; Kroon FP; Bollemeyer JG; Stricker BH; van 't Wout JW
Neth J Med; 1996 Jun; 48(6):211-5. PubMed ID: 8710040
[TBL] [Abstract][Full Text] [Related]
8. Treatment of disseminated Mycobacterium avium complex disease: a clinician's perspective.
Benson CA
Res Microbiol; 1996; 147(1-2):16-24. PubMed ID: 8761717
[No Abstract] [Full Text] [Related]
9. Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Singer J; Zarowny DP; Deschênes J; Phillips P; Turgeon F; Aoki FY; Toma E; Miller M; Duperval R; Lemieux C; Schlech WF
J Infect Dis; 1998 Jan; 177(1):252-5. PubMed ID: 9419201
[TBL] [Abstract][Full Text] [Related]
10. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Talbot JA; Chomyc S; Davison E; Singer J; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG
Clin Infect Dis; 1998 Dec; 27(6):1401-5. PubMed ID: 9868650
[TBL] [Abstract][Full Text] [Related]
11. [Management of atypical Mycobacterium infections in AIDS-patients].
Internist (Berl); 1996 Apr; 37(4 Suppl):1-8. PubMed ID: 9131082
[No Abstract] [Full Text] [Related]
12. [Uveitis associated with rifabutin treatment. Apropos of 3 patients].
Chevalley GF; Kaiser L; Bouchenaki N; Baglivo E; Kress O
Klin Monbl Augenheilkd; 1995 May; 206(5):388-90. PubMed ID: 7609395
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of triple drug regimen of amikacin, ethambutol and rifabutin in AIDS patients with symptomatic Mycobacterium avium complex infection.
Jorup-Rönström C; Julander I; Petrini B
J Infect; 1993 Jan; 26(1):67-70. PubMed ID: 8384230
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of Mycobacterium avium complex infection.
Mangura BT; Reichman LB
Res Microbiol; 1994; 145(3):181-7. PubMed ID: 7809470
[No Abstract] [Full Text] [Related]
15. Control of disease progress in Mycobacterium avium-infected AIDS patients.
Hoffner SE; Källenius G; Svenson SB
Res Microbiol; 1992 May; 143(4):391-8. PubMed ID: 1455066
[No Abstract] [Full Text] [Related]
16. [Rifabutin-induced hypopyon iritis in HIV infection].
Diemer PR; Zeh EW; Weidle EG
Klin Monbl Augenheilkd; 1996 Jul; 209(1):40-2. PubMed ID: 8965476
[TBL] [Abstract][Full Text] [Related]
17. [Mycobacterium avium intracellulare pericarditis in patients with AIDS. A case report and literature review].
Montero M; Cercós A; Navarro V; Santos M
Enferm Infecc Microbiol Clin; 2007 Nov; 25(9):606-7. PubMed ID: 17953906
[No Abstract] [Full Text] [Related]
18. Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network.
Shafran SD; Deschênes J; Miller M; Phillips P; Toma E
N Engl J Med; 1994 Feb; 330(6):438-9. PubMed ID: 8284019
[No Abstract] [Full Text] [Related]
19. MAC management.
PI Perspect; 1996 Nov; (No 20):16-7. PubMed ID: 11363967
[TBL] [Abstract][Full Text] [Related]
20. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
Ward TT; Rimland D; Kauffman C; Huycke M; Evans TG; Heifets L
Clin Infect Dis; 1998 Nov; 27(5):1278-85. PubMed ID: 9827282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
